Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVT.115959 for diabetic neuropathic pain
2006-005967-25Phase 2Completed
- Sponsor
- Sobi
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic neuropathy and type 2 diabetes mellitus (T2DM) comparing BVT.115959 with Placebo (2 arms). Primary endpoint: Change in 24-hour pain intensity score at Week 4. Started Jan 2007; status: completed.
02
Drugs
BVT-115959
03
Conditions
diabetic neuropathytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-005967-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005967-25.